SEC Form 4 · accession 0000899243-16-016231
Mirati Therapeutics, Inc. · MRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Braslyn Ltd.
10% Owner
Period of report
Mar 17, 2016
Accepted (ET)
Mar 17, 2016 · 5:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001576263
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 17, 2016 | J | 375,298 | $0.00 | A | 1,523,987 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On March 17, 2016, Boxer Asset Management Inc. ("Boxer Management") transferred 375,298 shares of the common stock of the issuer to Braslyn Ltd. ("Braslyn") for no consideration as part of an internal reorganization.
- F2These securities are owned directly by Braslyn, which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, LLC, (ii) Boxer Management, (iii) MVA Investors, LLC, (iv) the reporting person, (v) Joe Lewis, (vi) Christopher Fuglesang, (vii) Rodney W. Lappe, (viii) Ivan M. Lieberburg, (ix) Neil Reisman, (x) Shehan B. Dissanayake, (xi) Peter E. Harwin, and (xii) William N. Harwin 2012 Gift Trust F/B/O Peter Harwin. Joe Lewis is the sole indirect owner of and controls Braslyn.